42
Views
82
CrossRef citations to date
0
Altmetric
Mammalian Genetic Models with Minimal or Complex Phenotypes

Preserved Pancreatic β-Cell Development and Function in Mice Lacking the Insulin Receptor-Related Receptor

, , , , &
Pages 5624-5630 | Received 10 Jan 2001, Accepted 15 May 2001, Published online: 28 Mar 2023

REFERENCES

  • Accili, D., J. Drago, E. J. Lee, M. D. Johnson, M. H. Cool, P. Salvatore, L. D. Asico, P. A. Jose, S. I. Taylor, and H. Westphal. 1996. Early neonatal death in mice homozygous for a null allele of the insulin receptor gene. Nat. Genet. 12:106–109.
  • Accili, D., C. Frapier, L. Mosthaf, C. McKeon, S. C. Elbein, M. A. Permutt, E. Ramos, E. Lander, A. Ullrich, and S. I. Taylor. 1989. A mutation in the insulin receptor gene that impairs transport of the receptor to the plasma membrane and causes insulin-resistant diabetes. EMBO J. 8:2509–2517.
  • Accili, D., T. Kadowaki, H. Kadowaki, L. Mosthaf, A. Ullrich, and S. I. Taylor. 1992. Immunoglobulin heavy chain-binding protein binds to misfolded mutant insulin receptors with mutations in the extracellular domain. J. Biol. Chem. 267:586–590.
  • Bates, C. M., J. M. Merenmies, K. S. Kelly-Spratt, and L. F. Parada. 1997. Insulin receptor-related receptor expression in non-A intercalated cells in the kidney. Kidney Int. 52:674–681.
  • Beerli, R. R., D. Graus-Porta, K. Woods-Cook, X. Chen, Y. Yarden, and N. E. Hynes. 1995. Neu differentiation factor activation of ErbB-3 and ErbB-4 is cell specific and displays a differential requirement for ErbB-2. Mol. Cell. Biol. 15:6496–6505.
  • Bonner-Weir, S.. 2000. Life and death of the pancreatic beta cells. Trends Endocrinol. Metab. 11:375–378.
  • Bruning, J. C., M. D. Michael, J. N. Winnay, T. Hayashi, D. Horsch, D. Accili, L. J. Goodyear, and C. R. Kahn. 1998. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol. Cell 2:559–569.
  • Bruning, J. C., J. Winnay, W. S. Bonner, S. I. Taylor, D. Accili, and C. R. Kahn. 1997. Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles. Cell 88:561–572.
  • Graus-Porta, D., R. R. Beerli, J. M. Daly, and N. E. Hynes. 1997. ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling. EMBO J. 16:1647–1655.
  • Hirayama, I., H. Tamemoto, H. Yokota, S. K. Kubo, J. Wang, H. Kuwano, Y. Nagamachi, T. Takeuchi, and T. Izumi. 1999. Insulin receptor-related receptor is expressed in pancreatic beta-cells and stimulates tyrosine phosphorylation of insulin receptor substrate-1 and -2. Diabetes 48:1237–1244.
  • Hugl, S. R., M. F. White, and C. J. Rhodes. 1998. Insulin-like growth factor I (IGF-I)-stimulated pancreatic beta-cell growth is glucose-dependent. Synergistic activation of insulin receptor substrate-mediated signal transduction pathways by glucose and IGF-I in INS-1 cells. J. Biol. Chem. 273:17771–17779.
  • Itoh, N., K. Jobo, K. Tsujimoto, M. Ohta, and T. Kawasaki. 1993. Two truncated forms of rat insulin receptor-related receptor. J. Biol. Chem. 268:17983–17986.
  • Jui, H. Y., D. Accili, and S. I. Taylor. 1996. Characterization of a hybrid receptor formed by dimerization of the insulin receptor-related receptor (IRR) with the insulin receptor (IR): coexpression of cDNAs encoding human IRR and human IR in NIH-3T3 cells. Biochemistry 35:14326–14330.
  • Jui, H. Y., Y. Suzuki, D. Accili, and S. I. Taylor. 1994. Expression of a cDNA encoding the human insulin receptor-related receptor. J. Biol. Chem. 269:22446–22452.
  • Kadowaki, T.. 2000. Insights into insulin resistance and type 2 diabetes from knockout mouse models. J. Clin. Investig. 106:459–465.
  • Kahn, B. B.. 1998. Type 2 diabetes: when insulin secretion fails to compensate for insulin resistance. Cell 92:593–596.
  • Kelly-Spratt, K. S., L. J. Klesse, J. Merenmies, and L. F. Parada. 1999. A TrkB/insulin receptor-related receptor chimeric receptor induces PC12 cell differentiation and exhibits prolonged activation of mitogen-activated protein kinase. Cell Growth Differ. 10:805–812.
  • Kido, Y., D. J. Burks, D. Withers, J. C. Bruning, C. R. Kahn, M. F. White, and D. Accili. 2000. Tissue-specific insulin resistance in mice with combined mutations of insulin receptor, IRS-1 and IRS-2. J. Clin. Investig. 105:199–205.
  • Kido, Y., N. Philippe, A. A. Schaeffer, and D. Accili. 2000. Genetic modifiers of the insulin resistance phenotype. Diabetes 49:589–596.
  • Kovacina, K. S., and R. A. Roth. 1995. Characterization of the endogenous insulin receptor-related receptor in neuroblastomas. J. Biol. Chem. 270:1881–1887.
  • Kubota, N., K. Tobe, Y. Terauchi, K. Eto, T. Yamauchi, R. Suzuki, Y. Tsubamoto, K. Komeda, R. Nakano, H. Miki, S. Satoh, H. Sekihara, S. Sciacchitano, M. Lesniak, S. Aizawa, R. Nagai, S. Kimura, Y. Akanuma, S. I. Taylor, and T. Kadowaki. 2000. Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia. Diabetes 49:1880–1889.
  • Kulkarni, R. N., J. C. Bruning, J. N. Winnay, C. Postic, M. A. Magnuson, and C. R. Kahn. 1999. Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 96:329–339.
  • Kulkarni, R. N., J. N. Winnay, M. Daniels, J. C. Bruning, S. N. Flier, D. Hanahan, and C. R. Kahn. 1999. Altered function of insulin receptor substrate-1-deficient mouse islets and cultured beta-cell lines. J. Clin. Investig. 104:R69–R75.
  • Kurachi, H., K. Jobo, M. Ohta, T. Kawasaki, and N. Itoh. 1992. A new member of the insulin receptor family, insulin receptor-related receptor, is expressed preferentially in the kidney. Biochem. Biophys. Res. Commun. 187:934–939.
  • Leibiger, I. B., B. Leibiger, T. Moede, and P. O. Berggren. 1998. Exocytosis of insulin promotes insulin gene transcription via the insulin receptor/PI-3 kinase/p70 s6 kinase and CaM kinase pathways. Mol. Cell 1:933–938.
  • Mansour, S. L., K. R. Thomas, and M. R. Capecchi. 1988. Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes. Nature 336:348–352.
  • Mathi, S. K., J. Chan, and V. M. Watt. 1995. Insulin receptor-related receptor messenger ribonucleic acid: quantitative distribution and localization to subpopulations of epithelial cells in stomach and kidney. Endocrinology 136:4125–4132.
  • Nielsen, F. C., and S. Gammeltoft. 1988. Insulin-like growth factors are mitogens for rat pheochromocytoma PC 12 cells. Biochem. Biophys. Res. Commun. 154:1018–1023.
  • Ohmichi, M., L. Pang, V. Ribon, and A. R. Saltiel. 1993. Divergence of signaling pathways for insulin in PC-12 pheochromocytoma cells. Endocrinology 133:46–56.
  • Olayioye, M. A., R. M. Neve, H. A. Lane, and N. E. Hynes. 2000. The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J. 19:3159–3167.
  • Ozaki, K.. 1998. Insulin receptor-related receptor in rat islets of Langerhans. Eur. J. Endocrinol. 139:244–247.
  • Ozaki, K., N. Takada, K. Tsujimoto, N. Tsuji, T. Kawamura, E. Muso, M. Ohta, and N. Itoh. 1997. Localization of insulin receptor-related receptor in the rat kidney. Kidney Int. 52:694–698.
  • Polonsky, K. S., J. Sturis, and G. I. Bell. 1996. Non-insulin-dependent diabetes mellitus—a genetically programmed failure of the beta cell to compensate for insulin resistance. N. Engl. J. Med. 334:777–783.
  • Reinhardt, R. R., E. Chin, B. Zhang, R. A. Roth, and C. A. Bondy. 1993. Insulin receptor-related receptor messenger ribonucleic acid is focally expressed in sympathetic and sensory neurons and renal distal tubule cells. Endocrinology 133:3–10.
  • Reinhardt, R. R., E. Chin, B. Zhang, R. A. Roth, and C. A. Bondy. 1994. Selective coexpression of insulin receptor-related receptor (IRR) and TRK in NGF-sensitive neurons. J. Neurosci. 14:4674–4683.
  • Rhodes, C. J.. 2000. IGF-I and GH post-receptor signaling mechanisms for pancreatic beta- cell replication. J. Mol. Endocrinol. 24:303–311.
  • Schlessinger, J.. 2000. Cell signaling by receptor tyrosine kinases. Cell 103:211–225.
  • Schuppin, G. T., S. Pons, S. Hugl, L. P. Aiello, G. L. King, M. White, and C. J. Rhodes. 1998. A specific increased expression of insulin receptor substrate 2 in pancreatic beta-cell lines is involved in mediating serum-stimulated beta-cell growth. Diabetes 47:1074–1085.
  • Shier, P., and V. M. Watt. 1989. Primary structure of a putative receptor for a ligand of the insulin family. J. Biol. Chem. 264:14605–14608.
  • Shier, P., and V. M. Watt. 1992. Tissue-specific expression of the rat insulin receptor-related receptor gene. Mol. Endocrinol. 6:723–729.
  • Taylor, S. I.. 1999. Deconstructing type 2 diabetes. Cell 97:9–12.
  • Tsuji, N., K. Tsujimoto, N. Takada, K. Ozaki, M. Ohta, and N. Itoh. 1996. Expression of insulin receptor-related receptor in the rat brain examined by in situ hybridization and immunohistochemistry. Brain Res. Mol. Brain Res. 41:250–258.
  • Tsujimoto, K., N. Tsuji, K. Ozaki, M. Minami, M. Satoh, and N. Itoh. 1995. Expression of insulin receptor-related receptor mRNA in the rat brain is highly restricted to forebrain cholinergic neurons. Neurosci. Lett. 188:105–108.
  • Tsujimoto, K., N. Tsuji, K. Ozaki, M. Ohta, and N. Itoh. 1995. Insulin receptor-related receptor messenger ribonucleic acid in the stomach is focally expressed in the enterochromaffin-like cells. Endocrinology 136:558–561.
  • Tzahar, E., R. Pinkas-Kramarski, J. D. Moyer, L. N. Klapper, I. Alroy, G. Levkowitz, M. Shelly, S. Henis, M. Eisenstein, B. J. Ratzkin, M. Sela, G. C. Andrews, and Y. Yarden. 1997. Bivalence of EGF-like ligands drives the ErbB signaling network. EMBO J. 16:4938–4950.
  • Weiner, H. L., M. Rothman, D. C. Miller, and E. B. Ziff. 1996. Pediatric brain tumors express multiple receptor tyrosine kinases including novel cell adhesion kinases. Pediatr. Neurosurg. 25:64–72.
  • Withers, D. J., D. J. Burks, H. H. Towery, S. L. Altamuro, C. L. Flint, and M. F. White. 1999. Irs-2 coordinates Igf-1 receptor-mediated beta-cell development and peripheral insulin signalling. Nat. Genet. 23:32–40.
  • Withers, D. J., J. Sanchez-Gutierrez, H. Towery, D. J. Burks, J.-M. Ren, S. Previs, Y. Zhang, D. Bernal, S. Pons, G. I. Shulman, S. Bonner-Weir, and M. F. White. 1998. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391:900–904.
  • Zhang, B., and R. A. Roth. 1992. The insulin receptor-related receptor. Tissue expression, ligand binding specificity, and signaling capabilities. J. Biol. Chem. 267:18320–18328.
  • Zhao, A. Z., H. Zhao, J. Teague, W. Fujimoto, and J. A. Beavo. 1997. Attenuation of insulin secretion by insulin-like growth factor 1 is mediated through activation of phosphodiesterase 3B. Proc. Natl. Acad. Sci. USA 94:3223–3228.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.